TrialAnnals of hematology2023

Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.

Steffen Koschmieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.